{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:15:07Z","timestamp":1790252107498,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cmi.2018.06.023","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T19:39:03Z","timestamp":1530214743000},"page":"1039-1045","source":"Crossref","is-referenced-by-count":50,"title":["Update on vaccines for enteric pathogens"],"prefix":"10.1016","volume":"24","author":[{"given":"M.S.","family":"Riddle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.06.023_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib2","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1016\/j.vaccine.2017.05.035","article-title":"Chronic consequences on human health induced by microbial pathogens: growth faltering among children in developing countries","volume":"35","author":"Nataro","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax007","article-title":"Global travel patterns: an overview","volume":"24","author":"Glaesser","year":"2017","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib4","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1017\/S0950268814003185","article-title":"An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years","volume":"143","author":"Scallan","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2018.06.023_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ajg.2012.65","article-title":"Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis","volume":"107","author":"Verdu","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cmi.2018.06.023_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/cid\/cix369","article-title":"Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006\u20132016","volume":"65","author":"Jonesteller","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib7","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jix186","article-title":"Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea","volume":"215","author":"Burnett","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib8","first-page":"1192","article-title":"Implementation of rotavirus surveillance and vaccine introduction \u2013 World Health Organization African region, 2007\u20132016","volume":"66","author":"Mwenda","year":"2017","journal-title":"MMWR"},{"key":"10.1016\/j.cmi.2018.06.023_bib9","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.vaccine.2014.04.079","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life","volume":"32","author":"Bhandari","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib10","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A\u00a0randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.03.076","article-title":"The rotavirus vaccine development pipeline","author":"Kirkwood","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib12","first-page":"1","article-title":"Improving rotavirus vaccine coverage: can newer-generation and locally produced vaccines help?","author":"Deen","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2018.06.023_bib13","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1016\/j.vaccine.2011.07.118","article-title":"A\u00a0dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children","volume":"30","author":"Dang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1473-3099(15)00227-3","article-title":"Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Bines","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1473-3099(17)30242-6","article-title":"Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Groome","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14760584.2017.1255553","article-title":"The unrecognized burden of typhoid fever","volume":"16","author":"Obaro","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib18","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2018.06.023_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12879-015-1159-6","article-title":"Typhoid fever cases in the US military","volume":"15","author":"Sorrell","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/inthealth\/ihv018","article-title":"Enteric fever and its impact on returning travellers","volume":"7","author":"Dave","year":"2015","journal-title":"Internat Health"},{"key":"10.1016\/j.cmi.2018.06.023_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fpubh.2015.00269","article-title":"Vaccines through centuries: major cornerstones of global health","volume":"3","author":"Hajj Hussein","year":"2015","journal-title":"Front Public Health"},{"key":"10.1016\/j.cmi.2018.06.023_bib22","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1708-8305.2010.00405.x","article-title":"Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake","volume":"17","author":"Namikawa","year":"2010","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1708-8305.2008.00284.x","article-title":"Pretravel health preparation among US residents traveling to India to VFRs: importance of ethnicity in defining VFRs","volume":"16","author":"Baggett","year":"2009","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005274","article-title":"Whole genome sequence analysis of Salmonella Typhi isolated in Thailand before and after the introduction of a national immunization program","volume":"11","author":"Dyson","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.puhe.2006.06.008","article-title":"Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform","volume":"120","author":"Agtini","year":"2006","journal-title":"Public Health"},{"key":"10.1016\/j.cmi.2018.06.023_bib27","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide\u2013protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2018.06.023_bib28","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2018.06.023_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"New Eng J Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib30","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children","volume":"72","author":"Canh","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2018.06.023_bib31","series-title":"Typbar TCV\u00ae from Bharat Biotech, World's first typhoid conjugate vaccine prequalified by WHO [press release]","year":"2018"},{"key":"10.1016\/j.cmi.2018.06.023_bib32","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi\u2013tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib33","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.vaccine.2017.08.001","volume":"35","author":"Meiring","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002925","article-title":"Estimating the burden of paratyphoid a in Asia and Africa","volume":"8","author":"Arndt","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2051013614537819","article-title":"Killed oral cholera vaccines: history, development and implementation challenges","volume":"2","author":"Lopez","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008603.pub2","article-title":"Oral vaccines for preventing cholera","author":"Sinclair","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2018.06.023_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib39","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib41","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak?","volume":"22","author":"Calain","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib44","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib45","first-page":"437","article-title":"Deployments from the oral cholera vaccine stockpile, 2013\u20132017","volume":"92","year":"2017","journal-title":"Releve Epidemiologique Hebdomadaire"},{"key":"10.1016\/j.cmi.2018.06.023_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib49","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"key":"10.1016\/j.cmi.2018.06.023_bib51","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/315051","article-title":"Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR","volume":"180","author":"Lagos","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib52","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4161\/hv.29199","article-title":"Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines","volume":"10","author":"Desai","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2018.06.023_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/fmb-2017-0128","article-title":"Causes of impaired oral vaccine efficacy in developing countries","volume":"13","author":"Parker","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2018.06.023_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib55","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review","volume":"74","author":"Riddle","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2018.06.023_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","article-title":"Global etiology of travelers' diarrhea: systematic review from 1973 to the present","volume":"80","author":"Shah","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2018.06.023_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case\u2013control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib58","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2018.06.023_bib59","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1017\/S0950268814003446","article-title":"Comparison of resistance to third-generation cephalosporins in Shigella between Europe\u2013America and Asia\u2013Africa from 1998 to 2012","volume":"143","author":"Gu","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2018.06.023_bib60","series-title":"Tackling drug-resistant infections globally: final report and recommendations (The Review on Antimicrobial Resistance)","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.cmi.2018.06.023_bib61","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra1207777","article-title":"Enteropathogens and chronic illness in returning travelers","volume":"368","author":"Ross","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/21645515.2015.1011578","article-title":"Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: vaccines for Shigella, Salmonella, enterotoxigenic E.\u00a0coli (ETEC) enterohemorragic E.\u00a0coli (EHEC) and Campylobacter jejuni","volume":"11","author":"O'Ryan","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2018.06.023_bib63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.06.023_bib64","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.02713-12","article-title":"Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries","volume":"51","author":"Lindsay","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.06.023_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/erv.12.135","article-title":"Recent progress towards development of a Shigella vaccine","volume":"12","author":"Camacho","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib66","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib67","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14760584.5.5.669","article-title":"Live-attenuated Shigella vaccines","volume":"5","author":"Venkatesan","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib68","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.vaccine.2014.11.049","article-title":"An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib69","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","article-title":"Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1\u20134-year-old Israeli children","volume":"28","author":"Passwell","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.06.023_bib71","first-page":"51","article-title":"Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli","volume":"26","author":"Ravenscroft","year":"2016","journal-title":"Glycobiol"},{"key":"10.1016\/j.cmi.2018.06.023_bib72","series-title":"Vaccines for enteric diseases; 9\u201311 October 2017, NAU Sao Rafael Atlantico Hotel, Albufeira, Portugal","article-title":"Flexyn2a, a candidate bioconjugate vaccine against Shigella flexneri 2a induces protective immune response in a controlled human infection mode","author":"Talaat","year":"2017"},{"key":"10.1016\/j.cmi.2018.06.023_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","article-title":"Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, intradermally and intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe","volume":"22","author":"Launay","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmi.2018.06.023_bib74","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2017.01884","article-title":"A\u00a0phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a shigellosis-endemic country","volume":"8","author":"Obiero","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2018.06.023_bib75","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib76","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"Kotloff","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.09.083","article-title":"Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy","author":"Hosangadi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00052-05","article-title":"Prevention and self-treatment of traveler's diarrhea","volume":"19","author":"Diemert","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2018.06.023_bib79","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.2006.75.762","article-title":"Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom","volume":"75","author":"Monteville","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2018.06.023_bib80","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2016.02.076","article-title":"Status of vaccine research and development for enterotoxigenic Escherichia coli","volume":"34","author":"Bourgeois","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib81","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.vaccine.2017.06.006","article-title":"Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine ETVAX","volume":"35","author":"Leach","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.07.011","article-title":"Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell\/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea","volume":"108","author":"Borde","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cmi.2018.06.023_bib83","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14760584.2016.1178069","article-title":"New insights into the global burden of noroviruses and opportunities for prevention","volume":"15","author":"Hall","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2018.06.023_bib84","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.vaccine.2016.03.077","article-title":"Status of vaccine research and development for norovirus","volume":"34","author":"Riddle","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2018.06.023_bib85","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cmi.2018.06.023_bib86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J\u00a0Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18304889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18304889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:59:17Z","timestamp":1604509157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18304889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1198743X18304889"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.06.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}